These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9885978)

  • 1. Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograft.
    Van Alewijk DC; Van der Weiden MM; Eussen BJ; Van Den Andel-Thijssen LD; Ehren-van Eekelen CC; König JJ; van Steenbrugge GJ; Dinjens WN; Trapman J
    Genes Chromosomes Cancer; 1999 Feb; 24(2):119-26. PubMed ID: 9885978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
    Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density screen of human tumor cell lines for homozygous deletions of loci on chromosome arm 8p.
    Levy A; Dang UC; Bookstein R
    Genes Chromosomes Cancer; 1999 Jan; 24(1):42-7. PubMed ID: 9892107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
    Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
    Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of chromosomal region 6q14-16 in prostate cancer.
    Verhagen PC; Hermans KG; Brok MO; van Weerden WM; Tilanus MG; de Weger RA; Boon TA; Trapman J
    Int J Cancer; 2002 Nov; 102(2):142-7. PubMed ID: 12385009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer.
    Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT
    Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
    Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
    Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer.
    Oba K; Matsuyama H; Yoshihiro S; Kishi F; Takahashi M; Tsukamoto M; Kinjo M; Sagiyama K; Naito K
    Cancer Genet Cytogenet; 2001 Jan; 124(1):20-6. PubMed ID: 11165318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion mapping at 12p12-13 in metastatic prostate cancer.
    Kibel AS; Freije D; Isaacs WB; Bova GS
    Genes Chromosomes Cancer; 1999 Jul; 25(3):270-6. PubMed ID: 10379873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.
    Arbieva ZH; Banerjee K; Kim SY; Edassery SL; Maniatis VS; Horrigan SK; Westbrook CA
    Genome Res; 2000 Feb; 10(2):244-57. PubMed ID: 10673282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
    Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
    Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
    Bell SM; Zuo J; Myers RM; Knowles MA
    Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletions define a region of 8p23.2 containing a putative tumor suppressor gene.
    Sun PC; Schmidt AP; Pashia ME; Sunwoo JB; Scholnick SB
    Genomics; 1999 Dec; 62(2):184-8. PubMed ID: 10610711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
    Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
    Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
    Prasad MA; Trybus TM; Wojno KJ; Macoska JA
    Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.